Open AccessA comparative study of bloodstream infections in acute myeloid leukemia according to different phases of treatment: Can we predict the organism?
Author(s) -
Preetam Kalaskar,
Asha Anand,
Harsha Panchal,
Apurva Patel,
Sonia Parikh,
Sandip Shah
Publication year - 2017
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/2278-330x.214584
Subject(s) - medicine , cytarabine , myeloid leukemia , sepsis , blood culture , bacteremia , leukemia , incidence (geometry) , antibiotics , immunology , microbiology and biotechnology , biology , physics , optics
The treatment of acute myeloid leukemia (AML) consists of induction therapy with anthracyclines and cytarabine followed by two to four cycles of consolidation therapy with high-dose cytarabine after achieving remission. There have been very few studies comparing infections during induction and consolidation. We have analyzed blood cultures of patients with AML during episodes of fever occurring during induction and consolidation, for comparing the bloodstream infections in both the phases.